Insiders the biggest winners as Ouro Fino Saúde Animal Participações S.A.'s (BVMF:OFSA3) market cap rises to R$961m
Key Insights
- Ouro Fino Saúde Animal Participações' significant insider ownership suggests inherent interests in company's expansion
- The top 2 shareholders own 58% of the company
- Ownership research, combined with past performance data can help provide a good understanding of opportunities in a stock
A look at the shareholders of Ouro Fino Saúde Animal Participações S.A. (BVMF:OFSA3) can tell us which group is most powerful. We can see that individual insiders own the lion's share in the company with 56% ownership. In other words, the group stands to gain the most (or lose the most) from their investment into the company.
As a result, insiders were the biggest beneficiaries of last week’s 11% gain.
In the chart below, we zoom in on the different ownership groups of Ouro Fino Saúde Animal Participações.
View our latest analysis for Ouro Fino Saúde Animal Participações
What Does The Institutional Ownership Tell Us About Ouro Fino Saúde Animal Participações?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
Since institutions own only a small portion of Ouro Fino Saúde Animal Participações, many may not have spent much time considering the stock. But it's clear that some have; and they liked it enough to buy in. So if the company itself can improve over time, we may well see more institutional buyers in the future. When multiple institutional investors want to buy shares, we often see a rising share price. The past revenue trajectory (shown below) can be an indication of future growth, but there are no guarantees.
We note that hedge funds don't have a meaningful investment in Ouro Fino Saúde Animal Participações. The company's largest shareholder is Mitsui & Co., Ltd., with ownership of 30%. With 29% and 28% of the shares outstanding respectively, Jardel Massari and Norival Bonamichi are the second and third largest shareholders. Norival Bonamichi, who is the third-largest shareholder, also happens to hold the title of Vice Chairman.
After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.
While it makes sense to study institutional ownership data for a company, it also makes sense to study analyst sentiments to know which way the wind is blowing. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.
Insider Ownership Of Ouro Fino Saúde Animal Participações
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
Our information suggests that insiders own more than half of Ouro Fino Saúde Animal Participações S.A.. This gives them effective control of the company. That means they own R$543m worth of shares in the R$961m company. That's quite meaningful. Most would argue this is a positive, showing strong alignment with shareholders. You can click here to see if those insiders have been buying or selling.
General Public Ownership
The general public-- including retail investors -- own 10% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.
Public Company Ownership
Public companies currently own 30% of Ouro Fino Saúde Animal Participações stock. It's hard to say for sure but this suggests they have entwined business interests. This might be a strategic stake, so it's worth watching this space for changes in ownership.
Next Steps:
It's always worth thinking about the different groups who own shares in a company. But to understand Ouro Fino Saúde Animal Participações better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 1 warning sign for Ouro Fino Saúde Animal Participações you should know about.
If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, backed by strong financial data.
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About BOVESPA:OFSA3
Ouro Fino Saúde Animal Participações
Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.
Excellent balance sheet with questionable track record.